Aleksandra Szczęsna

Author

Aleksandra Szczęsna

Also Known As

A Szczesna, A Szczęsna, A. Szczesna, A. Szczęsna, Aleksandra Szczesna, Aleksandra Szczésna, Aleksandra Szczêsna, Aleksandra Szczęsna, Manuel Domine

105

Publications

11.9K

Citations

H-Index

Concepts

All Affiliations

Centrum Leczenia Oparzeń Asklepios Fachkliniken München-Gauting Poznan University of Medical Sciences The Christie Hospital LungenClinic Grosshansdorf

About

Aleksandra Szczęsna is an author at Centrum Leczenia Oparzeń specializing in oncology, cancer therapeutics, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	27	5.4K
2	Pathology	12	12	1K
3	Pharmacology	10	10	2.4K
4	Health Sciences	9	9	2.3K
5	Immunology	4	4	869

Aleksandra Szczęsna

Publications

11.6K

Citations

H-Index

Page 1

	Year	Citations
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer Leora Horn, Aaron S. Mansfield, Aleksandra Szczęsna, New England Journal of Medicine	2018	3.3K
Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna, The Lancet MedicineMetronomic TherapyPhase Iii TrialBronchial NeoplasmCancer Treatment	2009	1.4K
Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study Federico Cappuzzo, Tudor–Eliade Ciuleanu, Lilia Stelmakh, The Lancet Oncology Placebo-controlled Phase 3Maintenance TreatmentMedicineCancer ManagementPharmacology	2010	1.2K
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group Frank V. Fossella, Jose R. Pereira, Joachim von Pawel, Journal of Clinical Oncology	2003	942
Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation Trial U. Gatzemeier, Aleksandra Szczęsna, E. Kaukel, Journal of Clinical Oncology	2007	878
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer Martin Reck, Alexander Luft, Aleksandra Szczęsna, Journal of Clinical Oncology Antifibrotic TherapyOncologyIpilimumab Plus EtoposideMedicineMetronomic Therapy	2016	526
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial Nick Thatcher, Fred R. Hirsch, Alexander Luft, The Lancet Oncology First-line TherapyMedicinePathologyImmune Checkpoint InhibitorCisplatin Versus Gemcitabine	2015	472
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study Fabrice Barlési, Johan Vansteenkiste, David R. Spigel, The Lancet Oncology MedicineMetronomic TherapyClinical TrialsJavelin Lung 200Bronchial Neoplasm	2018	394
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer Ramaswamy Govindan, Aleksandra Szczęsna, Myung‐Ju Ahn, Journal of Clinical Oncology Antifibrotic TherapyOncologyAdvanced Squamous NsclcMedicineIpilimumab Combined	2017	374
Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer Mark A. Socinski, Egbert F. Smit, Paul Lorigan, Journal of Clinical Oncology	2009	212

Page 1